Rotem Sigall Boneh R.D.
Scientific Advisory Board Member
Claimed by owner Evinature
Former names:
Natural Remedies for IBD
Evinature
www.biopharmadive.com
•
Dec 15, 2022
Evinature exits stealth with $2 million funding to optimize global healthcare for patients with IBD, Crohn's, or Colitis through evidence-based natural remedies | BioPharma Dive
techbullion.com
•
Nov 25, 2022
How Evinature Spearheads the Gold Standard in Evidence-Based Natural Remedies for IBD, Crohn's, and Colitis
original.newsbreak.com
•
Nov 21, 2022
Evinature's CEO Apan Amos Damri On Providing Evidence-Based Natural Remedies to Patients with IBD, Crohn's, and Colitis | Market Analysis | NewsBreak Original
About
Evinature is leading cutting-edge research in integrative therapies for irritable bowel syndrome (IBD). The company sources, develops, and distributes clinically proven nutraceuticals, providing patients around the world with access to accurate diagnosis and treatment through its proprietary online platform.
The Evinature platform guides patients through the CurQD Protocol, natural, tailored treatment regimes. The CurQD Protocol has been successfully implemented into standard clinical practice in medical centers in Israel.
The Evinature platform guides patients through the CurQD Protocol, natural, tailored treatment regimes. The CurQD Protocol has been successfully implemented into standard clinical practice in medical centers in Israel.
Primary Sector
Life Sciences & HealthTech
Products
Agile, CurQD, Cura, Exhale
Geographic markets
North America, Israel, Bahamas, Bosnia and Herzegovina, Poland, Kuwait, Hong Kong, South Africa, Western Europe, Australia, Turkey, Singapore, Honduras, Cyprus, Colombia, United Arab Emirates, New Zealand, South Korea, Romania
News
(3)
www.biopharmadive.com
•
Dec 15, 2022
Evinature exits stealth with $2 million funding to optimize global healthcare for patients with IBD, Crohn's, or Colitis through evidence-based natural remedies | BioPharma Dive
techbullion.com
•
Nov 25, 2022
How Evinature Spearheads the Gold Standard in Evidence-Based Natural Remedies for IBD, Crohn's, and Colitis
original.newsbreak.com
•
Nov 21, 2022
Evinature's CEO Apan Amos Damri On Providing Evidence-Based Natural Remedies to Patients with IBD, Crohn's, and Colitis | Market Analysis | NewsBreak Original
The Team
(11)William D. Chey M.D.
Scientific Advisory Board Member
David T. Rubin M.D.
Scientific Advisory Board Member
Apan Amos Damri
Founder & CEO
Nir Salomon
Founder & Head of R&D
Shomron Ben-Horin M.D.
Founder and Chief Medical Officer
Uri Efrati
Chief Marketing Officer
Shiri Mazor
Chief Operations Officer
Ella Lorentz
Business Office Manager
Jonathan Schwartzman
Community and Marketing Manager
Tessa Eskin
Content Manager
Connect with
What is the reason for connecting?
Your company *
Your position *
Add invitation message
0/300
Sending invitation...
Company Lifecycle
Private Equity Funding
Seed
$2M
Jun 2022
1 Investors
$2M
Media gallery
(3)
Sample Product Image
Locations
Israel
HaMelacha St 3, Binyamina-Giv'at Ada, Israel
Locations
Israel
HaMelacha St 3, Binyamina-Giv'at Ada, Israel
Unlock financial data
Finder is provided for free by the non-profit organization Start-Up Nation Central.
- Get unlimited search results
- Save to custom lists - Smartlists
- Get notified with news and updates
- Connect with people
And much more...
I already have access,